46 research outputs found
Comparison of two telemetric intestinal temperature devices with rectal temperature during exercise.
The experienced discomfort of rectal probes and esophageal probes for the estimation of body core temperatures has triggered the development of GI-capsules that are easy acceptable for athletes and workers due to their non-invasive characteristics. We compare two new GI-capsule devices with rectal temperature during cycle ergometer exercise and rest. Eight participants followed a protocol of (i) 30 min exercise with a power output of 130 W, (ii) 5 min rest, (iii) 10 min self-paced maximum exercise, and (iv) 15 min rest. Core temperature was measured using two GI-capsule devices (e-Celsius and myTemp) and rectal temperature. The myTemp system gave temperatures indifferent different from rectal temperature during rest and exercise. However, the factory calibrated e-Celsius system, showed a systematic underestimation of rectal temperature of 0.2 °C that is corrected in the 2018 versions. Finally, both GI-capsules react faster to temperature changes in the body compared to the rectal temperature probe during the rest period following maximum exercise
Veränderungen im Cannabiskonsum 2004 bis 2007, Ergebnisse des Schweizerischen Cannabismonitorings
From the vendor in the hemp shop to the dealer in the alleyway? A comparison of the sources of supply of cannabis in a time of 'de-normalising' cannabis use.
Objectives: After several years of increasing 'normalisation' of cannabis use in Switzerland at the
beginning of the new millennium, a reversed tendency, marked among others by a more stringent
law-enforcement, set in. The presentation examines the question of where adolescents and young
adults obtained cannabis, within the context of this societal change. In addition, it compares the
sources of supply for cannabis with those found in studies of other European countries.
Methods: Analyses are based on data from the Swiss Cannabis Monitoring Study. As part of this
longitudinal, representative population survey, more than 5000 adolescents and young adults
were interviewed by telephone on the topic of cannabis. Within the total sample, 593 (2004) or
554 (2007) respectively, current cannabis users replied to the questions on sources of supply.
Changes in law-enforcement and societal climate concerning cannabis are assessed based on
relevant literature, media reports and parliamentary discussions.
Results: Whereas 22% of cannabis users stated in 2004 that they bought their cannabis from
vendors in hemp shops, this proportion drastically decreased to 6% three years later. At the same
time, cannabis was obtained increasingly from friends, while the proportion of users who
purchased cannabis from dealers in the alleyway, more than doubled from 6% (2004) to 13%
(2007). It was male cannabis users, and in particular, young adult and frequent users, who have
moved into the alleyways. Generally, users who buy cannabis in the alleyway show more
cannabis-related problems than those who mainly name other sources of supply, even when
adjusted for sex, age and frequency of cannabis use.
Discussion: Possible consequences of these changes in cannabis supply, like the risk of merging a
previously cannabis-only market with other 'harder' drugs markets, are discussed
How to screen for problematic cannabis use in population surveys? Towards a revised version of the Cannabis Use Disorders Identification Test (CUDIT)
How to screen for problematic cannabis use in population surveys. An Evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss sample of adolescents and young adults
BACKGROUND/AIMS: Cannabis use is a growing challenge for public health, calling for adequate instruments to identify problematic consumption patterns. The Cannabis Use Disorders Identification Test (CUDIT) is a 10-item questionnaire used for screening cannabis abuse and dependency. The present study evaluated that screening instrument. METHODS: In a representative population sample of 5,025 Swiss adolescents and young adults, 593 current cannabis users replied to the CUDIT. Internal consistency was examined by means of Cronbach's alpha and confirmatory factor analysis. In addition, the CUDIT was compared to accepted concepts of problematic cannabis use (e.g. using cannabis and driving). ROC analyses were used to test the CUDIT's discriminative ability and to determine an appropriate cut-off. RESULTS: Two items ('injuries' and 'hours being stoned') had loadings below 0.5 on the unidimensional construct and correlated lower than 0.4 with the total CUDIT score. All concepts of problematic cannabis use were related to CUDIT scores. An ideal cut-off between six and eight points was found. CONCLUSIONS: Although the CUDIT seems to be a promising instrument to identify problematic cannabis use, there is a need to revise some of its items
Transcriptional analysis of polydnaviral genes in the course of parasitization reveals segment-specific patterns
Trends on cannabis use and markets in Europe : the case of Switzerland : the end of normalisation?
A means of improving public health in low- and middle-income countries? Benefits and challenges of international public-private partnerships
In the last two decades international public-private partnerships have become increasingly important to improving public health in low- and middle-income countries. Governments realize that involving the private sector in projects for financing, innovation, development, and distribution can make a valuable contribution to overcoming major health challenges. Private-public partnerships for health can generate numerous benefits but may also raise some concerns. To guide best practice for public-private partnerships for health to maximize benefits and minimize risks, the first step is to identify potential benefits, challenges, and motives. We define motives as the reasons why private partners enter partnerships with a public partner.; We conducted a systematic review of the literature using the PRISMA guidelines.; We reviewed the literature on the benefits and challenges of public-private partnerships for health in low- and middle-income countries provided by international pharmaceutical companies and other health-related companies. We provide a description of these benefits, challenges, as well as of motives of private partners to join partnerships. An approach of systematic categorization was used to conduct this research.; We identified six potential benefits, seven challenges, and three motives. Our main finding was a significant gap in the available academic literature on this subject. Further empirical research using both qualitative and quantitative approaches is required. From the limited information that is readily available, we conclude that public-private partnerships for health imply several benefits but with some noticeable and crucial limitations.; In this article, we provide a description of these benefits and challenges, discuss key themes, and conclude that empirical research is required to determine the full extent of the challenges addressed in the literature
Can reduce - the effects of chat-counseling and web-based self-help, web-based self-help alone and a waiting list control program on cannabis use in problematic cannabis users: a randomized controlled trial
BACKGROUND: In European countries, including Switzerland, as well as in many states worldwide, cannabis is the most widely used psychoactive substance after alcohol and tobacco. Although approximately one in ten users develop serious problems of dependency, only a minority attends outpatient addiction counseling centers. The offer of a combined web-based self-help and chat counseling treatment could potentially also reach those users who hesitate to approach such treatment centers and help them to reduce their cannabis use.Methods/design: This paper presents the protocol for a three-armed randomized controlled trial that will test the effectiveness of a web-based self-help intervention in combination with, or independent of, tailored chat counseling compared to a waiting list in reducing or enabling the abstention from cannabis use in problematic users. The primary outcome will be the weekly quantity of cannabis used. Secondary outcome measures will include the number of days per week on which cannabis is used, the severity of cannabis use disorder, the severity of cannabis dependence, cannabis withdrawal symptoms, cannabis craving, the use of alcohol, tobacco, and other non-cannabis illicit drugs, changes in mental health symptoms, and treatment retention. The self-help intervention will consist of 8 modules designed to reduce cannabis use based on the principles of motivational interviewing, self-control practices, and methods of cognitive behavioral therapy. The two additional individual chat-counseling sessions in the additional chat condition will be based on the same therapy approaches and tailored to participants' self-help information data and personal problems. The predictive validity of participants' baseline characteristics on treatment retention and outcomes will be explored. DISCUSSION: To the best of our knowledge, this will be the first randomized controlled trial to test the effectiveness of online self-help therapy in combination or without chat counseling in reducing or enabling the abstention from cannabis use. It will also investigate predictors of outcome and retention for these interventions. This trial is registered at Current Controlled Trials and is traceable as ISRCTN59948178
